Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

NCT06765733 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT06765733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06765733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
May 31, 2025
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy - parkinsonian subtype (msa-p), multiple system atrophy, msa